JCI (Johnson Controls International plc) Stock Analysis - Insider Trades
Johnson Controls International plc (JCI) is a publicly traded Industrials sector company. As of May 20, 2026, JCI trades at $138.04 with a market cap of $83.77B and a P/E ratio of 24.85. JCI moved +1.61% today. Year to date, JCI is +13.35%; over the trailing twelve months it is +41.06%. Its 52-week range spans $68.03 to $147.32. Analyst consensus is buy with an average price target of $150.92. Rallies surfaces JCI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading JCI stock inside the company?
Recent JCI insider activity includes Grabowski Todd M sold 4.27K, Schlitz Lei Zhang sold 48.07K, Schlitz Lei Zhang sold 14.70K, Schlitz Lei Zhang sold 25.14K, and Schlitz Lei Zhang sold 900. Rallies tracks insider transaction dates, shares, prices, and estimated values.
JCI Key Metrics
Key financial metrics for JCI
Metric
Value
Price
$138.04
Market Cap
$83.77B
P/E Ratio
24.85
EPS
$5.54
Dividend Yield
0.40%
52-Week High
$147.32
52-Week Low
$68.03
Volume
2.92M
Avg Volume
0
Revenue (TTM)
$24.43B
Net Income
$3.68B
Gross Margin
36.56%
Recent JCI Insider Trades
Grabowski Todd M sold 4.27K (~$621.87K) on May 14, 2026.
Schlitz Lei Zhang sold 48.07K (~$6.78M) on May 8, 2026.
Schlitz Lei Zhang sold 14.70K (~$2.08M) on May 8, 2026.
Schlitz Lei Zhang sold 25.14K (~$3.53M) on May 8, 2026.
Schlitz Lei Zhang sold 900 (~$127.14K) on May 8, 2026.
Recent JCI insider activity includes Grabowski Todd M sold 4.27K, Schlitz Lei Zhang sold 48.07K, Schlitz Lei Zhang sold 14.70K, Schlitz Lei Zhang sold 25.14K, and Schlitz Lei Zhang sold 900. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for JCI?
Yes. Rallies tracks JCI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is JCI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for JCI. It does not provide personalized investment advice.